8-143598513-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032862.5(TIGD5):āc.610A>Gā(p.Lys204Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00018 in 1,359,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032862.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TIGD5 | NM_032862.5 | c.610A>G | p.Lys204Glu | missense_variant | 1/1 | ENST00000504548.4 | NP_116251.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TIGD5 | ENST00000504548.4 | c.610A>G | p.Lys204Glu | missense_variant | 1/1 | 6 | NM_032862.5 | ENSP00000421489.2 | ||
EEF1D | ENST00000533749.5 | c.41+768T>C | intron_variant | 5 | ENSP00000431933.1 |
Frequencies
GnomAD3 genomes AF: 0.000957 AC: 144AN: 150392Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000835 AC: 101AN: 1208998Hom.: 0 Cov.: 32 AF XY: 0.0000682 AC XY: 40AN XY: 586264
GnomAD4 genome AF: 0.000957 AC: 144AN: 150498Hom.: 0 Cov.: 32 AF XY: 0.000939 AC XY: 69AN XY: 73504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2021 | The c.610A>G (p.K204E) alteration is located in exon 1 (coding exon 1) of the TIGD5 gene. This alteration results from a A to G substitution at nucleotide position 610, causing the lysine (K) at amino acid position 204 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at